期刊文献+

胸腺瘤MSCT征象与PCNA及MMP-2表达的相关性 被引量:2

Correlation of PCNA and MMP-2 expression with multi-slice spiral CT manifestations of thymoma
下载PDF
导出
摘要 目的:探讨胸腺瘤MSCT征象与增殖细胞核抗原(PCNA)、基质金属蛋白酶2(MMP-2)在胸腺瘤组织中表达的相关性。方法:对46例胸腺瘤患者行MSCT平扫,其中21例行增强扫描,所有胸腺瘤标本行免疫组化SP法染色,分析MSCT征象与PCNA、MMP-2表达水平的相关性。结果:胸腺瘤CT征象中的病灶直径大于10cm,分叶征,病灶边缘不光滑,纵膈脂肪线消失,胸膜、心包及大血管侵犯,纵隔淋巴结、远处转移及病灶高强化程度与胸腺瘤组织PCNA及MMP-2的高表达具有显著相关性(P<0.05)。结论:MSCT征象能在一定程度上反映胸腺瘤的病理学特点,有利于术前无创地评估肿瘤生物学行为。 Objective:To investigate the correlation of proliferating cell nuclear antigen(PCNA) and metris metalloproteinase-9(MMP-2) expression with multi-slice spiral CT(MSCT) manifestations of thymoma.Methods:Fourty-six thymoma patients underwent MSCT scanning,21 of them also had enhanced CT.All of the thymoma specimen had immuno-histochemistry SP staining,the correlation of MSCT findings with PCNA and MMP-2 expression were studied.Results:Significant correlation was observed between high PCNA and MMP-2 expression with the following CT findings such as tumor diameter 10cm,lobulation,ill-defined margin,invasion of pleura,pericardium and great vessels within mediastinum and loss of mediastinal fat,distal/ mediastinal lymph node metastases and marked enhancement(P0.05).Conclusion:Certain MSCT findings can reflect the pathology characteristics of thymoma,which might be served as a noninvasive modality for preoperative evaluation of thymoma.
出处 《放射学实践》 2012年第4期390-393,共4页 Radiologic Practice
关键词 胸腺瘤 免疫组织化学 增殖细胞核抗原 基质金属蛋白酶2 体层摄影术 X线计算机 Thymoma Immunohistochemistry Proliferating cell nuclear antigen Matrix metalloproteinase 2 Tomography X-ray computed
  • 相关文献

参考文献10

  • 1陈迪 丁嘉安 等.原发性纵隔肿瘤的外科治疗(附101例分析)[J].中华肿瘤杂志,1981,3(3):200-203.
  • 2Dworakowska D,Gozdz S,Jassem E,et al.Prognostic relevance of proliferating cell nuclear antigen and P53 expression in non-small cell lung cancer[J].Lung Cancer,2002,35(1):35-41.
  • 3Micheal BN,Robert MB,Rogert BF,et al.Identify of the proliferating cell nuclear antigen and cyclin[J].Nature,1984,309 (5):374-376.
  • 4Bravo R,Frank R,Blundell PA,et al.Cyclin/PCNA is the auxiliary protein of DNA polymerase-delta[J].Nature,1987,326(6112):515-517.
  • 5Curran S,Murray GI.Matrix metalloproteinases in tumor invasion and metastasis[J].J Pathol,1999,189 (3):300-308.
  • 6印洪林,吴剑平,周晓军,孟奎,陆珍凤.B1型胸腺瘤25例临床病理研究[J].诊断病理学杂志,2002,9(1):9-11. 被引量:9
  • 7Richard RF,Williamw R.Thymoma:benign appearance,malignant potential[J].Oncologist,2006,11(8):887-894.
  • 8葛建立,王培军.CT对恶性胸腺瘤诊断价值的探讨[J].实用放射学杂志,1997,13(12):734-736. 被引量:8
  • 9李文波,白林,付凯,蒲红,赵世煜.恶性胸腺瘤WHO病理分类及其CT表现[J].医学影像学杂志,2006,16(5):463-465. 被引量:14
  • 10李英,于铁链,李东,曹阳.胸腺上皮肿瘤MSCT影像与WHO组织学分型的对照分析[J].中国医学影像技术,2009,25(3):431-433. 被引量:17

二级参考文献25

  • 1张志庸,任华,于洪泉,李泽坚,孙成孚,徐乐天,刘鸿瑞.影响胸腺肿瘤切除与预后的诸因素分析[J].中华肿瘤杂志,1994,16(5):375-378. 被引量:13
  • 2Cameron RB,Loehrer PJ,Thomas CR Jr.Neoplasms of the mediastinum.In:DeVita VT Jr,Hellman S,Rosenberg SA,et al.Cancer:principles and practice of oncology.6th ed.Philadelphia:Lippincott-Raven Publishers,2000:1019-1036.
  • 3Chalabreysse L,Roy P,Cordier JF,et al.Correlation of the WHO schema for the classification of thymic epithelial neoplasms with prognosis.Am J Surg Pathol,2002,26(12):1605-1611.
  • 4Travis WD,Brambilla E,Muller-Hermelink HK,et al.WHO classification of tumors pathology and genetics of tumours of the lung,pleura,thymus and heart.Paris.Lyon:IARC Press,2004:145-197.
  • 5Jeong YJ,Lee KS,Kim J,et al.Does CT of thymic epithelial tumors enable us to differentiate histologic subtypes and predict prognosis.AJR Am J Roentgenol,2004,183(2):283-289.
  • 6Nishino M,Ashiku SK,Kocher ON,et al.The thymus:a comprehensive review.Radiographics,2006,26(2):335-348.
  • 7Rieker RJ,Hoegel J,Morresi-Hauf A,et al.Histologic classification of thymic epithelial tumors:comparison of established classification schemes.Int J Cancer,2002,98(6):900-906.
  • 8Okumura M,Ohta M,Tateyama H,et al.The World Health Organization histologic classification system reflects the oncologic behavior of thymoma.Cancer,2002,94(3):624-632.
  • 9Duwe BV,Sterman DH,Musani AI,et al.Tumors of the mediastinum.Chest,2005,128(4):2893-2909.
  • 10Santana L,Givica A,Camacho C,et al.Best cases from the AFIP:thymoma.Radiographics,2002,22:S95-S102.

共引文献42

同被引文献21

  • 1Engels EA,Pfeiffer RM.Malignant thymoma in the UnitedStates:demographic patterns in incidence and associations withsubsequent malignancies[J],Int J Cancer,2003,105(4):546-551.
  • 2Travis WD,Brambilla E,Muller-Hermelink HK,et al.WHO clas-sification of tumors.Pathology and genetics of tumors of the lung,pleura,thymus and heart[M].Lyon:IARC Press,2004:177-178.
  • 3Yanagawa M,Tomiyama N.Prediction of thymoma histology andstage by radiographic criteria[J].Thorac Surg Clin,2011,21(1):1-12.
  • 4Marom EM,Milito MA,Moran CA,et al.Computed tomographyfindings predicting invasiveness of thymoma[J].J Thorac Oncol,2011,6(7);1274-1281.
  • 5Priola AM,Priola SM,Di Franco M,et al.Computed tomographyand thymoma:distinctive findings in invasive and noninvasive thy-moma and predictive features of recurrence[J].Radiol Med,2010,115(1):1-21.
  • 6Weissferdt A,Moran CA.Staging of primary mediastinal tumors[J].Adv Anat Pathol,2013,20(1):1-9.
  • 7Okumura M,Ohta M,Miyoshi S,et al.Oncological significance ofWHO histological thymoma classification.A clinical study basedon 286 patients[J].Jpn J Thorac Cardiovasc Surg,2002,50(5):189-194.
  • 8Sadohara J,Fujimoto K,Muller NL,et al.Thymic epithelialtumors:comparison of CT and MR imaging findings of low-riskthymomas,high-risk thymomas,and thymic carcinomas[J].EurJ Radiol,2006,60(1):70-79.
  • 9Casey EM,Kiel PJtLoehrer PJ.Clinical management of thymomapatients[J].Hematol Oncol Clin North Am,2008,22(3):457-473.
  • 10张文玉,黄勇,申洪明,李文武.多层螺旋CT在低危、高危胸腺瘤及胸腺癌鉴别诊断中的应用[J].中国临床医学影像杂志,2011,22(9):612-615. 被引量:16

引证文献2

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部